Kindly find enclosed herewith the extracts of Newspaper Publication Pursuant to Reg 47 of SEBI (LODR) Regulations, 2015 of the Audited Standalone & Consolidated Financial Results for the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Shree Pacetronix Ltd, a cardiac pacing medical devices company, published its audited financial results for Q4 and FY ended March 31, 2026. Standalone total income for Q4 grew 26% to ₹541.18 lakhs from ₹430.68 lakhs in Q4 FY25. Net profit after tax for Q4 stood at ₹126.98 lakhs, nearly doubling from ₹65.07 lakhs year-on-year. For the full year, standalone net profit after tax was ₹408.69 lakhs (vs ₹421.36 lakhs in FY25), showing a slight decline of about 3%. Basic EPS improved in Q4 to ₹2.67 (from ₹1.29) and full-year EPS was ₹8.31. Consolidated results were nearly identical to standalone, indicating no significant subsidiaries. The results were approved by the Board on May 25, 2026 and published on May 26, 2026.
The quarterly earnings show strong sequential improvement with net profit nearly doubling year-on-year, though full-year profit declined slightly. The stock could see positive reaction given the Q4 momentum and EPS growth, despite minor full-year profit contraction.